Form 8-K - Current report:
SEC Accession No. 0000914475-25-000006
Filing Date
2025-01-27
Accepted
2025-01-27 16:12:01
Documents
15
Period of Report
2025-01-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20250124.htm   iXBRL 8-K 29792
2 EX-99.1 nbix2025127-exhibit991.htm EX-99.1 13215
6 GRAPHIC nbix-20250124_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-25-000006.txt   223429

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20250124.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20250124_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20250124_pre.xml EX-101.PRE 12514
17 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20250124_htm.xml XML 2716
Mailing Address 12780 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 25559154
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)